首页> 外文OA文献 >Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial
【2h】

Effectiveness of a Peer Support Programme versus Usual Care in Disease Management of Diabetes Mellitus Type 2 regarding Improvement of Metabolic Control: A Cluster-Randomised Controlled Trial

机译:同伴支持程序的有效性与糖尿病疾病管理疾病管理的常规护理有关改进代谢控制的蛋白:簇随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aim. Testing the effectiveness of peer support additionally to a disease management programme (DMP) for type 2 diabetes patients. Methods. Unblinded cluster-randomised controlled trial (RCT) involving 49 general practices, province of Salzburg, Austria. All patients enrolled in the DMP were eligible, n=337 participated (intervention: 148 in 19 clusters; control: 189 in 20 clusters). The peer support intervention ran over 24 months and consisted of peer supporter recruitment and training, and group meetings weekly for physical exercise and monthly for discussion of diabetes related topics. Results. At two-year follow-up, adjusted analysis revealed a nonsignificant difference in HbA1c change of 0.14% (21.97 mmol/mol) in favour of the intervention (95% CI −0.08 to 0.36%, p=0.22). Baseline values were 7.02 ± 1.25% in the intervention and 7.08 ± 1.25 in the control group. None of the secondary outcome measures showed significant differences except for improved quality of life (EQ-5D-VAS) in controls (4.3 points on a scale of 100; 95% CI 0.08 to 8.53, p=0.046) compared to the intervention group. Conclusion. Our peer support intervention as an additional DMP component showed no significant effect on HbA1c and secondary outcome measures. Further RTCs with a longer follow-up are needed to reveal whether peer support will have clinically relevant effects. Trial Registration. This trial has been registered with Current Controlled Trials Ltd. (ISRCTN10291077).
机译:目的。另外测试的对等体支持的有效性的疾病管理程序(DMP)的2型糖尿病的患者。方法。揭盲集群随机对照试验(RCT),涉及49种的一般做法,萨尔茨堡,奥地利省。所有患者参加了DMP有资格,N = 337参加(干预:148在19簇;控制:189在20簇)。在同行的支持干预跑过去24个月,由同行的支持者招聘和培训,并进行体育锻炼组会议每周和每月糖尿病讨论相关话题。结果。在两年的随访中,调整分析表明在0.14%的HbA1c变化有利于干预的无显着差异(21.97毫摩尔/摩尔)(95%CI -0.08〜0.36%,P = 0.22)。基线值在干预7.02±1.25%,而对照组中的7.08±1.25。的次要结果测量无显示,除了在控制生活质量的提高(EQ-5D-VAS)显著差异(在100分4.3分; 95%CI 0.08至8.53,P = 0.046)相比,在干预组。结论。我们同行的支持干预作为一个附加组件DMP表现出对HbA1c和二次结果的措施没有显著影响。需要有长期随访进一步的RTC透露同行的支持是否有临床意义的影响。试验注册。这项试验已注册当前对照试验有限公司(ISRCTN10291077)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号